Balyasny Asset Management L.P. 13F: Cuts AHR Stake by $51M

Balyasny Asset Management L.P. reduced its stake in American Healthcare REIT, Inc. (NYSE: AHR) by 985,000 shares in its latest Form 13F filing. The reduction represents a 45.7% decrease in holdings, leaving the fund with 1,168,129 shares valued at approximately $60.6 million as of the end of the reporting period on May 15, 2026.

What Changed in Balyasny Asset Management's Position

Balyasny Asset Management's cut means it now holds a significantly smaller stake compared to earlier, when it owned 2,153,129 shares. The current reduced holding reflects the fund's strategy in managing its investments as market conditions change.

Other Institutional Activity in American Healthcare REIT

Blackrock Inc. trimmed its holdings by 2,894,125 shares, ending with 25,845,948 shares worth about $1.37 billion. Meanwhile, Vanguard Portfolio Management LLC increased its stake by 851,352 shares, bringing its total to 16,975,438 shares valued at around $898.3 million. Vanguard Capital Management LLC also grew its holdings by 1,002,723 shares, totaling 9,201,599 shares valued at $486.9 million. State Street Corporation decreased its holdings by 499,216 shares, resulting in 9,046,025 shares worth approximately $478.7 million. Principal Financial Group, Inc. added 1,494,973 shares, now holding 8,917,875 shares valued at about $471.9 million.

American Healthcare REIT, Inc. Stock Down 2.1%

American Healthcare REIT shares were trading at $51.92 on the publication date, which is close to its 52-week high of $58.7. This trading range suggests that the stock has seen a strong recovery over the past year as it approaches its peak value.

Recent Earnings

In its latest earnings report, American Healthcare REIT posted revenue of approximately $2.5 billion, reflecting a growth rate of 24.7%. The company reported earnings per share (EPS) of $0.68 and a net margin of 4.83%. The next earnings report is scheduled for November 5, 2026.

Dividend

American Healthcare REIT pays an annual dividend rate of $1.00, providing a yield of 1.92%. This payout is part of the company’s strategy to return value to shareholders. The payout ratio stands at 147.06%.

Insider Buying and Selling at American Healthcare REIT, Inc.

On June 24, 2026, several insiders at American Healthcare REIT made notable transactions. Mark Foster, EVP, GC & Secretary, sold 2,500 shares at an average price of $48.58, valued at approximately $121,450. Other insiders, including Mathieu Streiff and Valerie Richardson, added 2,594 shares each, although the exact value of these transactions was not disclosed.

Analysts Set New Price Targets

On October 13, 2026, UBS maintained a Buy rating with a price target of $62.00, while Barclays also maintained an Overweight rating but adjusted its target down to $60.00 from $66.00. Raymond James initiated coverage with a Strong Buy rating and a target of $62.00. The consensus among analysts is a strong buy, with a mean price target of $64.40 based on 15 opinions.

About American Healthcare REIT

American Healthcare REIT, Inc. is a Maryland-based real estate investment trust (REIT) that manages a diverse portfolio of healthcare-related properties across the U.S., U.K., and the Isle of Man. The company focuses on senior housing, skilled nursing facilities, and outpatient medical buildings, utilizing a fully integrated management platform.

Bottom Line

Looking ahead, investors will watch for the next earnings report on November 5, 2026, for updates on performance. Balyasny's recent filing reflects its position as of mid-May and may not indicate current holdings, as institutional positions can change frequently.